Phase II trial of short-term neoadjuvant docetaxel and complete androgen blockade in high-risk prostate cancer

por Mellado, B, Font, A, Alcaraz, A, Aparicio, L A, Veiga, F J G, Areal, J, Gallardo, E, Hannaoui, N, Lorenzo, J R M, Sousa, A, Fernandez, P L, Gascon, P
Publicado 2009